Development of tolerance in mice to the sedative effects of the neuroactive steroid minaxolone following chronic exposure

被引:39
作者
Marshall, FH [1 ]
Stratton, SC [1 ]
Mullings, J [1 ]
Ford, E [1 ]
Worton, SP [1 ]
Oakley, NR [1 ]
Hagan, RM [1 ]
机构
[1] GLAXO WELLCOME MED RES CTR,DIS SCI DIV,STEVENAGE SG1 2NY,HERTS,ENGLAND
关键词
neurosteroid; minaxolone; GABA; GABA(A) receptor; temazepam; tolerance; locomotor activity;
D O I
10.1016/S0091-3057(96)00132-3
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Minaxolone is a potent ligand for the neurosteroid binding site of the GABA(A) receptor. In radioligand binding studies to rat brain membranes, minaxolone caused a 69% increase in [H-3]muscimol binding and a 25% increase in [H-3]flunitrazepam binding and inhibited the binding of [H-3]TBOB with an IC50 of 1 mu M. In mice, minaxolone (100 mg/kg, orally) had marked sedative effects as indicated by a reduction in locomotor activity. Chronic dosing with minaxolone (100 mg/kg, orally, once daily for 7 days) resulted in a loss of sedative response to an acute dose of the drug, indicating the development of tolerance. Chronic dosing with temazepam (10 mg/kg, orally, once daily for 7 days) resulted in the development of tolerance to an acute dose of temazepam; however, the two drugs did not appear to be cross-tolerant, indicating that they may have a different mechanism of action at the level of the GABAA receptor. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 23 条
[1]  
Backstrom T, 1985, Acta Obstet Gynecol Scand Suppl, V130, P19
[2]   ANTICONVULSANT PROFILE OF THE PROGESTERONE METABOLITE 5-ALPHA-PREGNAN-3-ALPHA-OL-20-ONE [J].
BELELLI, D ;
BOLGER, MB ;
GEE, KW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (02) :325-329
[3]   ANXIOLYTIC ACTIVITY OF AN ENDOGENOUS ADRENAL-STEROID [J].
CRAWLEY, JN ;
GLOWA, JR ;
MAJEWSKA, MD ;
PAUL, SM .
BRAIN RESEARCH, 1986, 398 (02) :382-385
[4]  
FRIEDMAN L, 1993, MOL PHARMACOL, V44, P191
[5]   DEPENDENCE, TOLERANCE, AND ADDICTION TO BENZODIAZEPINES - CLINICAL AND PHARMACOKINETIC CONSIDERATIONS [J].
GREENBLATT, DJ ;
SHADER, RI .
DRUG METABOLISM REVIEWS, 1978, 8 (01) :13-28
[6]   MODULATION OF THE GABA RECEPTOR COMPLEX BY A STEROID ANESTHETIC [J].
HARRISON, NL ;
SIMMONDS, MA .
BRAIN RESEARCH, 1984, 323 (02) :287-292
[7]  
HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346
[8]   EFFECTS OF CONTINUOUS DIAZEPAM ADMINISTRATION ON GABA-A SUBUNIT MESSENGER-RNA IN RAT-BRAIN [J].
HENINGER, C ;
SAITO, N ;
TALLMAN, JF ;
GARRETT, KM ;
VITEK, MP ;
DUMAN, RS ;
GALLAGER, DW .
JOURNAL OF MOLECULAR NEUROSCIENCE, 1990, 2 (02) :101-107
[9]   DECREASED GABA-A-RECEPTOR SUBUNIT MESSENGER-RNA CONCENTRATIONS FOLLOWING CHRONIC LORAZEPAM ADMINISTRATION [J].
KANG, I ;
MILLER, LG .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (02) :1285-1287
[10]   ANALGESIC EFFECTS OF THE PROGESTERONE METABOLITE, 3-ALPHA-HYDROXY-5-ALPHA-PREGNAN-20-ONE, AND POSSIBLE MODES OF ACTION IN MICE [J].
KAVALIERS, M ;
WIEBE, JP .
BRAIN RESEARCH, 1987, 415 (02) :393-398